{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Clinical trial", "Hypertension", "Obesity", "Vaccinium arctostaphylos"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31126570", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "09"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "05", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ctim.2019.05.010", "S0965-2299(19)30177-3"], "Journal": {"ISSN": "1873-6963", "JournalIssue": {"Volume": "44", "PubDate": {"Year": "2019", "Month": "Jun"}}, "Title": "Complementary therapies in medicine", "ISOAbbreviation": "Complement Ther Med"}, "ArticleTitle": "Antihypertensive efficacy and safety of Vaccinium arctostaphylos berry extract in overweight/obese hypertensive patients: A randomized, double-blind and placebo-controlled clinical trial.", "Pagination": {"StartPage": "296", "EndPage": "300", "MedlinePgn": "296-300"}, "Abstract": {"AbstractText": ["To evaluate the antihypertensive efficacy and safety of a standardized Vaccinium arctostaphylos (V. arctostaphylos) berry hydro-alcoholic extract in the overweight/obese hypertensive patients.", "Randomized placebo-controlled trial.", "Baqiyatallah hospital (Tehran, Iran).", "The antihypertensive efficacy and safety of 3-month intake of 400\u2009mg extract capsule three times daily alongside standardized anti-hypertensive regimen in the treatment of 50 patients was compared with the placebo (n\u2009=\u200950).", "SBP (systolic blood pressure), DBP (diastolic blood pressure), body mass index, waist circumference, CBC (complete blood count), blood levels of AST (aspartate aminotransferase), ALT (alanine aminotransferase), ALP (alkaline phosphatase), BUN (blood urea nitrogen) and creatinine.", "SBP decreased from 152.1\u2009\u00b1\u20097.7 to 140.5\u2009\u00b1\u200910.7 in the V. arctostaphylos group and from 152.9\u2009\u00b1\u20098.1 to 150.8\u2009\u00b1\u20099.3 in the placebo group (P\u2009<\u20090.001). DBP decreased from 90.3\u00b18 to 82.1\u00b18.8 in the V. arctostaphylos group and from 89.6\u2009\u00b1\u20097.8 to 87.6\u2009\u00b1\u20097.9 in the placebo group (P\u2009<\u20090.001). The extract capsule had no significant effect on the other parameters (P\u2009>\u20090.05). Moreover, no drug side effect and adverse interaction with other antihypertensive drugs was observed in the patients.", "V. arctostaphylosberry extract improves blood pressure control and has safety and tolerability in the overweight/obese hypertensive patients taking standard antihypertensive drugs."], "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran; Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran. Electronic address: skianbakht@yahoo.com."}], "LastName": "Kianbakht", "ForeName": "Saeed", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran; School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Hashem-Dabaghian", "ForeName": "Fataneh", "Initials": "F"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Scotland", "MedlineTA": "Complement Ther Med", "NlmUniqueID": "9308777", "ISSNLinking": "0965-2299"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antihypertensive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antihypertensive Agents"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Arctostaphylos"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": [], "DescriptorName": "Body Mass Index"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fruit"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hypertension"}, {"QualifierName": [], "DescriptorName": "Iran"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Obesity"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Overweight"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Vaccinium"}, {"QualifierName": ["drug effects"], "DescriptorName": "Waist Circumference"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "2", "Day": "3"}, {"Year": "2019", "Month": "4", "Day": "13"}, {"Year": "2019", "Month": "5", "Day": "7"}, {"Year": "2019", "Month": "5", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31126570", "10.1016/j.ctim.2019.05.010", "S0965-2299(19)30177-3"]}}]}